Ammar M Almaaytah (Ammar Almaaytah)

Publication Activity (10 Years)

Years Active: 2016-2019
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Helicobacter Pylori

Acinetobacter Baumannii

Top Venues

Molecules (Basel, Switzerland)

Infection and drug resistance

Pharmacy practice

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Samer Fuad Swedan, Zaina Shubair, Ammar M Almaaytah
Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae. Infection and drug resistance 12 (2019)
Qosay Ali Al-Balas, Mousa L Al-Smadi, Mohammad A Hassan, Ghazi A Al Jabal, Ammar M Almaaytah, Karem H Alzoubi
Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors. Molecules (Basel, Switzerland) 24 (18) (2019)
Ammar M Almaaytah, Ahmad Farajallah, Ahmad Abualhaijaa, Qosay Ali Al-Balas
A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria. Molecules (Basel, Switzerland) 23 (7) (2018)
Ammar M Almaaytah, Mohammed T Qaoud, Gubran Khalil Mohammed, Ahmad Abualhaijaa, Daniel Knappe, Ralf Hoffmann, Qosay Ali Al-Balas
Antimicrobial and Antibiofilm Activity of UP-5, an Ultrashort Antimicrobial Peptide Designed Using Only Arginine and Biphenylalanine. Pharmaceuticals (Basel, Switzerland) 11 (1) (2018)
Tareq L Mukattash, Wail A Hayajneh, Shorok M Ibrahim, Abeer Ayoub, Nehad Ayoub, Anan S Jarab, Maher Khdour, Ammar M Almaaytah
Prevalence and nature of off-label antibiotic prescribing for children in a tertiary setting: A descriptive study from Jordan. Pharmacy practice 14 (3) (2016)